Clicky

Haleon plc(HLN)

Description: Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.


Keywords: Consumer Healthcare Products Diclofenac Theraflu Advil Otrivin Panadol Polident Sensodyne Voltaren Centrum

Home Page: www.haleon.com

HLN Technical Analysis

Building 5
Weybridge, KT13 0NY
United Kingdom
Phone: 44 1932 822000


Officers

Name Title
Mr. Brian McNamara CEO & Exec. Director
Mr. Tobias Hestler CFO & Exec. Director
Ms. Amy Landucci Head of Digital and Technology
Mr. Bjarne Philip Tellmann Gen. Counsel
Ms. Tamara Rogers Chief Marketing Officer
Ms. Mairead Nayager Chief HR Officer
Mr. Bart Derde Head of Quality and Supply Chain
Mr. Filippo Lanzi Head of EMEA & LatAm
Ms. Teri Lyng Head of Transformation & Sustainability
Ms. Jooyong Lee Head of Strategy and Office of the CEO

Exchange: LSE

Country: UK

Currency: Pence sterling (p)

Forward PE: 15.6495
Trailing PE: 20.8567
Price-to-Book MRQ: 1.0802
Price-to-Sales TTM: 2.7822
IPO Date:
Fiscal Year End: December
Full Time Employees: 22000
Back to stocks